posted on 2025-03-20, 08:13authored byXuelian Fu, Beibei Chen, Man He, Guolin Yuan, Bin Hu
The isolation and detection of circulating
tumor cells
(CTCs) play
a significant role in early cancer diagnosis and prognosis. Negative
magnetophoresis sorting is a label-free method, providing easy access
to enrich intact and viable CTCs, but it struggles to meet the demands
of high-throughput separation and direct downstream analysis. In this
work, a facile cascaded negative magnetophoresis microfluidic chip
was fabricated and online coupled to inductively coupled plasma mass
spectrometry (ICP–MS) for the rapid separation and detection
of rare CTCs in blood samples. The chip consisted of two parts: a
negative magnetophoresis sorting zone and a negative magnetophoresis
phase-transfer zone. In the sorting zone, WBCs labeled with anti-CD45-magnetic
beads (MBs) dispersed in biocompatible ferrofluid were removed by
magnetic attractive force, while CTCs labeled with anti-EpCAM-Eu migrated
into the phase-transfer zone by magnetic repulsive force; in the phase-transfer
zone, due to the stable laminar flow formed by the magnetic fluid
and PBS buffer, CTCs migrated into the PBS under both the magnetic
repulsive force and inertial lift force and online introduced into
ICP–MS for detection. This device can achieve CTC enrichment
at a high throughput of 100 μL min–1 and has
the capability for direct downstream analysis and recultivation (cell
viability of 99.27%). The method was applied for the detection of
CTCs in real clinical blood samples from 10 patients diagnosed with
various cancers, and the detection rate was 100%, providing a simple
and efficient approach for clinical detection of rare CTCs.